Brown tumors are focal bone lesions, encountered in patients with uncontrolled hyperparathyroidism. They can be located in any part of the skeleton. Clinically significant lesions in the craniofacial bones are rare. Craniofacial involvement may cause facial disfiguration and compromise social ease of the patient and normal functions, such as chewing, talking, and breathing. In this case report, we present a patient with a brown tumor of the craniofacial bones provoked by secondary hyperparathyroidism and review the last 10 years of craniofacial brown tumors associated with secondary hyperparathyroidism in the English literature.
Introduction
Brown tumors are focal bone lesions, caused by increased osteoclastic activity and fibroblastic proliferation, encountered in patients with uncontrolled hyperparathyroidism (HPT). They can be located in any part of the skeleton, but are most frequently encountered in the ribs, clavicles, extremities, and pelvic girdle. Clinically significant lesions in the craniofacial bones are rare [1] .
Here, we present a patient with a brown tumor of the craniofacial bones provoked by secondary HPT. When we searched PubMed for English literature of the last 10 years, there were 26 cases of craniofacial brown tumors associated with secondary HPT. Of the 26 cases, full texts of 24 cases were available and a summary of these cases is shown in table 1.
Case Report
A 30-year-old Albanian female patient was referred to our hospital for living donor kidney transplantation. She was unable to walk without help and was restricted to a wheelchair. Her medical history included chronic renal insufficiency, hypertension, anemia, and hepatitis C. She had been undergoing dialysis three times per week for 19 years. A tumor was protruding through her oral cavity; it had appeared insidiously 10 years ago and had increased gradually in size. The lesion was fixed to the underlying mandible, was tender to the touch, and was covered with oral mucosa. The teeth were severely affected, and bleeding sites were observed on the fragile mucosa ( fig. 1 ). The patient had functional problems with chewing and speech. Serum chemistry revealed an elevated parathyroid hormone (PTH) level of 2,930.6 pg/dl (normal range, 15-65 pg/dl), serum calcium 9.08 mg/dl (normal range, 8.8-11 mg/dl), phosphorus 4.2 mg/dl (normal range, 2.5-5.0 mg/dl), and alkaline phosphatase (ALP) 1,753 IU/l (normal range, 65-300 IU/l).
A sagittal magnetic resonance imaging scan of the head showed a brown tumor originating from the mandibular and maxillary bones ( fig. 2 ). Ultrasonography of the neck revealed no parathyroid mass; however, a scan with 20 mCi Tc-99-sestamibi showed increased uptake by the parathyroid glands ( fig. 3 ). Based on the medical history, clinical manifestations, and laboratory tests, the final diagnosis was brown tumor with HPT. A whole-body scan with 20 mCi Tc-99m-HDP was performed to look for multifocal disease, which may have been missed. However, only maxillary and mandibular accumulation was observed.
A total parathyroidectomy was performed without implantation of a parathyroid fragment into the forearm muscle. PTH was monitored intraoperatively, and the PTH level decreased (355 pg/dl). A histopathological examination of the mass confirmed the diagnosis of parathyroid adenoma. Serum PTH level continued to decrease after surgery, and the laboratory findings 1 month postoperatively were PTH 127.2 pg/dl, ALP 247 IU/l, calcium 8.4 mg/dl, and phosphorus 2 mg/dl.
The lesion failed to regress 6 months postoperatively, despite optimal treatment for HPT. Kidney transplantation was performed with a living donor kidney from her cousin and creatinine levels decreased to normal postoperatively. No complications were observed during the first postoperative week, and the patient was discharged from the hospital.
Discussion
Here, we report a case of a huge brown tumor originating from the mandible and protruding through the oral cavity, which was provoked by secondary HPT. This tumor is of the longest duration reported among brown tumors provoked by secondary HPT that affected craniofacial bones (table 1). In fact, these tumors are not malignant, and there are options for management. Treating the HPT is the first step, and normalizing PTH level with drugs, dialysis, parathyroidectomy, or kidney transplantation will often cause the tumor to regress or resolve [1] . Surgical resection of a brown tumor is generally not recommended and should only be considered if the patient wants quick resolution, if the bony lesion is com-promising body functions or promoting facial deformation, or if the lesion fails to regress after 1-2 years of follow-up [2, 3] . The 10-year duration of our case was too long, reflecting the inadequacy of preventing and managing brown tumors in underdeveloped countries.
Brown tumors may be located in any part of the skeleton. Involvement of the mandible, maxilla, palate, nasal cavity, paranasal sinuses, and orbital and temporal bones has been reported [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] . The mandible is more commonly affected than the maxilla, and these tumors are usually asymptomatic except when large. Brown tumors may cause facial disfiguration and compromise social ease of the patient and normal functions, such as chewing, talking, and breathing. Other complications include headaches, visual impairment, proptosis of the eyes, displacement and mobility of the teeth, and nasal or intraoral bleeding [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] . The huge tumor in our case originated from the mandible and caused teeth to fall out and severely affected chewing. Talking and the appearance of our patient were also affected. This tumor caused surgical difficulties due to its location. Nasotracheal intubation and a tracheotomy were necessary for the surgery, but our team completed the procedure successfully.
Conclusion
This case was unique considering the severity and the absolute lack of response to parathyroidectomy. Despite the parathyroidectomy and optimal control of calcium/phosphate metabolism, the brown tumor did not decrease in size during follow-up, which was confirmed by computed tomography of the lesion. The mass remained also unchanged 1 year after transplantation and the surgical option will be assessed during the follow-up of the patient.
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